With one year until new rules on ‘high-risk’ AI systems take effect in the EU, pharmaceutical companies using AI in the process of drug development need clarity on whether the rules will apply to them ...

The US government’s new AI action plan is charting a “fundamentally divergent path” from the European Union by focusing on deregulation and national security, according to experts.

A new online system for granting and managing mineral licences is expected to bring greater regulatory clarity and investment opportunities to South Africa’s mining landscape, but continued delays in ...

The new EU and US trade deal averts a ‘trade war’ and should in principle provide businesses with welcomed stability, even if ...

A division of the Unified Patent Court (UPC) in Germany has banned a company from selling a product in the UK because it considers the product to infringe a European patent in force in the UK, even ...

While specific measures have not yet been disclosed, Rowland emphasised to the Australian Financial Review that the current legislation is “not fit for the digital age”, particularly considering the ...

Our dynamic and progressive Life Sciences team is nimble, creative and innovative in their approach to pushing the boundaries of science and law and bringing you closer to your aspirations and goals.